Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate

被引:0
作者
Sang-Won Lee
Hee-Jin Park
Beom Kyung Kim
Kwang-Hyub Han
Soo-Kon Lee
Seung Up Kim
Yong-Beom Park
机构
[1] Yonsei University College of Medicine,Department of Internal Medicine
[2] Yonsei University College of Medicine,Institute for Immunology and Immunological Diseases
[3] Yonsei University College of Medicine,Department of Medical Sciences
[4] Yonsei University College of Medicine,Institute of Gastroenterology
[5] Yonsei University College of Medicine,Liver Cirrhosis Clinical Research Center
来源
Arthritis Research & Therapy | / 14卷
关键词
Rheumatoid Arthritis; Rheumatoid Arthritis Patient; Chronic Liver Disease; Liver Fibrosis; Cumulative Dose;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Methotrexate and leflunomide: Biochemical basis for combination therapy in the treatment of rheumatoid arthritis
    Kremer, JM
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1999, 29 (01) : 14 - 26
  • [42] Combination leflunomide and methotrexate in refractory rheumatoid arthritis: a biologic sparing approach
    Hodkinson, Bridget
    Magomero, Kingsley Ross
    Tikly, Mohammed
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2016, 8 (05) : 172 - 179
  • [43] Risk factors associated with relapse after methotrexate dose reduction in patients with rheumatoid arthritis receiving golimumab and methotrexate combination therapy
    Kitamura, Noboru
    Kobayashi, Hitomi
    Nagasawa, Yosuke
    Sugiyama, Kaita
    Tsuzuki, Hiroshi
    Tanikawa, Yutaka
    Ikumi, Natsumi
    Okada, Yuito
    Takahashi, Yasuo
    Asai, Satoshi
    Tamura, Naoto
    Ogasawara, Michihiro
    Kawamoto, Toshio
    Kuwatsuru, Ryohei
    Tamaki, Hiromichi
    Kidoguchi, Genki
    Tateishi, Mutsuto
    Kimura, Makiko
    Mochida, Yuichi
    Harigane, Kengo
    Shimazaki, Takayuki
    Koike, Takao
    Tanimura, Kazuhide
    Kataoka, Hiroshi
    Amano, Koichi
    Yasuoka, Hidekata
    Takei, Masami
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (06) : 1058 - 1066
  • [44] Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis
    Osuga, Tatsuya
    Ikura, Yoshihiro
    Kadota, Chikara
    Hirano, Seiichi
    Iwai, Yasuhiro
    Hayakumo, Takanobu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 1961 - 1966
  • [45] A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate
    Hobl, E. -L.
    Jilma, B.
    Erlacher, L.
    Duhm, B.
    Mustak, M.
    Broell, H.
    Hoegger, P.
    Rizovski, B.
    Mader, R. M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (02) : 156 - 163
  • [46] Effects of methotrexate combined with leflunomide on efficacy, joint function and inflammatory factors in patients with rheumatoid arthritis
    Zhao, Baojing
    Wu, Xiudi
    Xiao, Dongmei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (12): : 9429 - 9438
  • [47] Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis
    Kim, Tae Yeob
    Kim, Ji Yeoun
    Sohn, Joo Hyun
    Lee, Hye-Soon
    Bang, So-Young
    Kim, Yongsoo
    Kim, Min Yeong
    Jeong, Woo Kyoung
    JOURNAL OF ULTRASOUND IN MEDICINE, 2015, 34 (09) : 1621 - 1630
  • [48] A PROSPECTIVE ANALYSIS OF LIVER BIOPSIES IN RHEUMATOID-ARTHRITIS PATIENTS RECEIVING LONG-TERM METHOTREXATE THERAPY
    TISHLER, M
    CASPI, D
    HALPERIN, Z
    BARATZ, M
    MOSHKOWITZ, M
    YARON, M
    RHEUMATOLOGY INTERNATIONAL, 1992, 12 (01) : 39 - 41
  • [49] Individualization of leflunomide dosing in rheumatoid arthritis patients
    Hopkins, Ashley M.
    O'Doherty, Catherine E.
    Foster, David J. R.
    Upton, Richard N.
    Proudman, Susanna M.
    Wiese, Michael D.
    PERSONALIZED MEDICINE, 2014, 11 (04) : 449 - 461
  • [50] Efficacy of Vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy
    Salesi, Mansour
    Farajzadegan, Ziba
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) : 2129 - 2133